Wells Fargo & Company Aptorum Group LTD Transaction History

Wells Fargo & Company

  • $434 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$2.37 - $3.43 $3,751 - $5,429
-1,583 Closed
0 $0
Q1 2021

May 13, 2021
SELL
$2.45 - $4.17 $1,225 - $2,085
-500 Reduced 24.0%
1,583 $5,000
Q4 2020

Feb 09, 2021
BUY
$2.03 - $2.89 $2,198 - $3,129
1,083 Added 108.3%
2,083 $5,000
Q3 2020

Nov 05, 2020
BUY
$1.22 - $4.76 $1,220 - $4,760
1,000 New
1,000 $3,000

Others Institutions Holding APM

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About Aptorum Group Ltd

APM Quotes by TradingView
  • Ticker APM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,265,500
  • Market Cap $8.76M
  • Description
  • Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline products include SACT- 1 for neuroblastoma and other cancer types; SACT-...
More about APM
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email